Genomic Valley Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

3.05

3.05

3.05

3.05

3.05

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

0.84

0.49

0.47

-0.18

1.43

Loan funds

Secured loans

-

0.60

0.61

-

1.55

Unsecured loans

-

-

-

-

-

Total

3.90

4.14

4.14

2.88

6.04

Uses of funds

Fixed assets

Gross block

0.01

-

0.48

2.57

6.60

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

0.48

0.82

0.74

Net block

0.01

-

-

1.75

5.86

Capital work-in-progress

-

-

-

-

0.49

Investments

-

0.02

-

-

-

Net current assets

Current assets, loans & advances

4.35

4.31

4.42

2.04

1.27

Less : current liabilities & provisions

0.46

0.19

0.28

0.92

1.58

Total net current assets

3.89

4.13

4.13

1.12

-0.31

Miscellaneous expenses not written

-

-

-

-

-

Total

3.90

4.14

4.14

2.88

6.04

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

30.55

30.55

30.55

30.55

30.55